(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AELIX

This trademark appears in the official USPTO history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILEDType: WordOffice: United States

Quick snapshot

AELIX

ST13

US500000079184331

Class

5, 35, 42

Filing

79184331

Registration

5088948

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Case type

Application and registration

Recorded events

36

Latest update

08/13/2026

Trademark type

Word

Nice classes

5, 35, 42

Filing date

01/19/2016

Registration date

11/29/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/19/2026

Last transaction

08/13/2026

Responsible office

United States Patent and Trademark Office

Status code

404

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

BARCELONA, ES

Examiner

SCHIMPF, TIMOTHY O

Law office

M40

Holders and representatives

Holders

A. S. (pessoa física)
A. S. (pessoa física)

Representatives

John G. Tutunjian Tutunjian & Bitetto, P.C.

Technical classification

Nice Classes

Class 5Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical productsvaccines and medicines for the treatment of HIV infection

Class 35

Commercial administration of the licensing of the goods of otherslicensing of pharmaceutical productsvaccines and medicines for the treatment of HIV infection; import-export agency services for pharmaceutical productsvaccines and medicines for the treatment of HIV infection; wholesale and retail store servicesin stores and via global telematic networksfeaturing pharmaceutical productsvaccines and medicines for the treatment of HIV infection

Class 42

Research and development of pharmaceutical productsvaccines and medicines for the treatment of HIV infection; conducting clinical trials for others for pharmaceutical productsvaccines and medicines for the treatment of HIV infection; medicalbiomedical and scientific research regarding HIV

Publications

History of USPTO decisions and trademark events.

36 publications found

DENA

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

08/13/2026

DETH

DEATH OF INTERNATIONAL REGISTRATION

08/13/2026

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

11/29/2025

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

09/25/2023

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

09/05/2023

INPC

INVALIDATION PROCESSED

09/05/2023

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

08/08/2023

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

12/08/2022

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

12/08/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/05/2022

ES71

TEAS SECTION 71 RECEIVED

06/23/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/29/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/01/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/13/2017

FIMP

FINAL DISPOSITION PROCESSED

03/13/2017

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/28/2017

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

12/02/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

11/29/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/13/2016

PUBO

PUBLISHED FOR OPPOSITION

09/13/2016

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/24/2016

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/24/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/24/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/04/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/03/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/02/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/02/2016

RFNP

REFUSAL PROCESSED BY IB

05/27/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/10/2016

RFRR

REFUSAL PROCESSED BY MPU

05/10/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/10/2016

CNRT

NON-FINAL ACTION WRITTEN

05/09/2016

DOCK

ASSIGNED TO EXAMINER

05/04/2016

MAFR

APPLICATION FILING RECEIPT MAILED

03/18/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/14/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/10/2016

Continuous trademark protection

Get notified about every new filing that threatens AELIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.